Format

Send to

Choose Destination
Curr Opin Obstet Gynecol. 2012 Aug;24(4):229-34. doi: 10.1097/GCO.0b013e32835585dc.

Recurrent miscarriage and thrombophilia: an update.

Author information

1
Liverpool Women's NHS Foundation Trust, Liverpool, UK. kellymcnamee@doctors.org.uk

Abstract

PURPOSE OF REVIEW:

Acquired and inherited thrombophilia is an important research avenue in the recurrent miscarriage field. The optimum treatment for patients with recurrent miscarriage and a confirmed thrombophilia remains a contentious issue. We aim to appraise and explore the latest research in the field of thrombophilia and recurrent miscarriage in this review.

RECENT FINDINGS:

Antiphospholipid syndrome (APS) is the only proven thrombophilia that is associated with adverse pregnancy outcomes. Research involving inherited thrombophilia and recurrent miscarriage is limited to small observational studies with small and heterogeneous populations. Aspirin and heparin therapy are frequently prescribed for APS, yet there is no robust evidence for the most efficacious regime. The combination of inherited hypercoagulability and environmental factors in association with recurrent miscarriage has recently been explored as an aid to identify high-risk individuals.

SUMMARY:

The cause of recurrent miscarriage is multifactorial and appropriate treatment continues to be a challenge. Laboratory tests need to be standardized and well designed multicentre research trials are essential to expand on the current knowledge base with the aim to produce strong evidence-based medicine.

PMID:
22729089
DOI:
10.1097/GCO.0b013e32835585dc
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center